Institution
Universiti Teknologi MARA
Education•Shah Alam, Malaysia•
About: Universiti Teknologi MARA is a education organization based out in Shah Alam, Malaysia. It is known for research contribution in the topics: Population & Thin film. The organization has 21838 authors who have published 27763 publications receiving 223876 citations. The organization is also known as: MARA University of Technology.
Topics: Population, Thin film, Computer science, Spin coating, Government
Papers published on a yearly basis
Papers
More filters
Population Health Research Institute1, National University of Ireland, Galway2, St. John's Medical College3, Mulago Hospital4, Eduardo Mondlane University5, Royal Perth Hospital6, University of the Philippines7, Universiti Teknologi MARA8, Copenhagen University Hospital9, University Hospital Bonn10, University of Miami11
TL;DR: The findings suggest that ten risk factors are associated with 90% of the risk of stroke, and targeted interventions that reduce blood pressure and smoking, and promote physical activity and a healthy diet, could substantially reduce the burden of stroke.
2,793 citations
Abstract: Recently, there has been a rapid growth in research and innovation in the natural fibre composite (NFC) area. Interest is warranted due to the advantages of these materials compared to others, such as synthetic fibre composites, including low environmental impact and low cost and support their potential across a wide range of applications. Much effort has gone into increasing their mechanical performance to extend the capabilities and applications of this group of materials. This review aims to provide an overview of the factors that affect the mechanical performance of NFCs and details achievements made with them.
2,182 citations
TL;DR: A review of chitosan composites for removing dyes and heavy metal ions can be found in this article, where a list of composites with their adsorption capacity and experimental conditions has been compiled.
1,746 citations
Population Health Research Institute1, Centra2, Charles University in Prague3, University of Washington Medical Center4, Brigham and Women's Hospital5, National University of Ireland, Galway6, University College London7, Jagiellonian University8, University of Würzburg9, Semmelweis University10, Karolinska Institutet11, University of the Philippines12, University of La Frontera13, University of Cape Town14, Aalborg University15, Katholieke Universiteit Leuven16, Catholic University of Korea17, Monash University18, Universiti Teknologi MARA19, Paris Diderot University20
TL;DR: Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better cardiovascular outcomes and more major bleeding events than those assign to aspirin alone.
Abstract: BackgroundWe evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. MethodsIn this double-blind trial, we randomly assigned 27,395 participants with stable atherosclerotic vascular disease to receive rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg once daily), rivaroxaban (5 mg twice daily), or aspirin (100 mg once daily). The primary outcome was a composite of cardiovascular death, stroke, or myocardial infarction. The study was stopped for superiority of the rivaroxaban-plus-aspirin group after a mean follow-up of 23 months. ResultsThe primary outcome occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (379 patients [4.1%] vs. 496 patients [5.4%]; hazard ratio, 0.76; 95% confidence interval [CI], 0.66 to 0.86; P<0.001; z=−4.126), but major bleeding events occurred in more patients in the rivaroxaban-plus-aspirin group (288 patients [3.1%] vs. 170 patients [1....
1,587 citations
National University of Ireland, Galway1, Population Health Research Institute2, St. John's Medical College3, Eduardo Mondlane University4, Glasgow Royal Infirmary5, Sahlgrenska University Hospital6, University of Western Australia7, University of the Philippines8, Mulago Hospital9, University Hospital Bonn10, Aga Khan University11, Universiti Teknologi MARA12, UCSI University13, Dubai Health Authority14, Istanbul Medeniyet University15, University of La Frontera16, University College Hospital, Ibadan17, University of Copenhagen18, Cayetano Heredia University19, University of Split20, Rush University Medical Center21, King Saud University22, University of Limpopo23, Mahidol University24
TL;DR: The importance of potentially modifiable risk factors for stroke in different regions of the world, and in key populations and primary pathological subtypes of stroke, was quantified.
1,313 citations
Authors
Showing all 22051 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| B.H. Hameed | 106 | 328 | 39456 |
| Sabu Thomas | 102 | 1554 | 51366 |
| Michael V. Swain | 91 | 739 | 31167 |
| Zainol Abidin Ibrahim | 78 | 688 | 29901 |
| Qing Li | 71 | 477 | 17151 |
| Martin Skitmore | 66 | 577 | 16212 |
| Arnan Mitchell | 64 | 597 | 14059 |
| Wan Ramli Wan Daud | 60 | 428 | 13522 |
| Meisam Tabatabaei | 56 | 288 | 13113 |
| Abdul Kariem Arof | 55 | 392 | 10877 |
| Anuar Mohd Ishak | 54 | 315 | 10264 |
| Ishak Hashim | 53 | 427 | 9312 |
| Paul Barnes | 52 | 301 | 9457 |
| Goangseup Zi | 45 | 153 | 8411 |
| Qiang Shen | 45 | 357 | 10013 |